Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Creatd, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2013
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
Revenue
0.01
0.01
0.77
0.22
0.1
0.09
0.45
1.21
4.3
4.8
Cost of revenue
0
0.18
0.04
1.5
5.3
6.11
Gross profit
0.01
0.58
0.18
0.1
0.08
0.45
-0.28
-1
-1.31
Research and development
0.59
0.64
1.13
0.26
0.98
0.95
Selling and marketing
2.85
9.63
4.7
General and administrative
0.07
0.28
0.52
1.05
1.33
1.67
6.54
6.03
4.56
9.73
Operating expenses
0.07
0.32
3.44
3.87
5.66
5.77
7.67
16
32.4
27.7
Operating income
-0.07
-0.31
-2.85
-3.69
-5.56
-5.69
-7.22
-16.3
-33.4
-29
Interest expense
-0
0.03
0.49
3.47
0.48
0.92
0.61
1.38
0.37
0.82
Interest income
0.4
0
Other non-operating income
-0
-0.03
-0.49
-3.7
-3.19
-6.33
-0.82
-7.93
-4.01
Pre-tax income
-0.33
-3.34
-7.39
-8.75
-12
-8.04
-24.2
-37.4
-35.7
Income tax
24.2
37.4
Net income
-0.08
-0.38
-3.34
-7.39
-8.75
-12
-8.04
-24.2
-37.3
-32.3
EBITDA
-0.07
-0.3
-2.84
-3.65
-5.52
-5.64
-7.16
-16.1
-33
-28.4
EPS, basic
-0.16
-0.41
-0.36
-0.69
-0.69
-12.44
-2.93
-5.68
-2.98
-1.66
EPS, diluted
-0.16
-0.41
-0.36
-0.69
-0.69
-12.44
-2.93
-5.68
-3.44
-1.60
Shares, basic (weighted)
0.5
0.94
9.53
10.7
12.9
1.14
2.74
4.81
12.7
22
Shares, diluted (weighted)
0.5
0.94
9.53
10.7
12.9
1.14
2.74
4.81
12.7
22
Balance sheet
FY2013
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
Cash and equivalents
1.48
0.13
0.44
0.17
0.11
0.01
7.91
3.79
0.71
Short-term investments
0
0
Receivables
0
0
0.01
0.05
0.09
0.34
0.24
Inventory
0.02
0.11
0.4
Other current assets
0
0.01
0
8.67
3.97
2.97
Total current assets
1.5
0.97
0.44
0.18
0.11
0.01
0.08
8.02
4.48
1.48
Property, plant and equipment
0.06
0.38
0.07
0.07
0.05
0.04
0.04
0.06
0.1
0.21
Lease right-of-use assets
0.31
0.24
0.02
2.05
Goodwill
1.04
1.04
1.37
0.05
Intangible assets
1.09
0.96
2.43
0.23
Long-term investments
0.06
Other non-current assets
0.01
Total assets
1.56
1.36
0.61
0.38
0.18
0.21
2.57
10.8
9.17
4.82
Accounts payable
0.01
0.02
0.68
1.39
-0.47
1.25
1.76
2.64
3.73
7.57
Accrued liabilities
0.08
0.26
0.47
Deferred revenue
0.01
0.05
0.09
0.23
0.3
Short-term debt
1.43
1.34
1.65
Total current liabilities
0.01
0.09
0.97
3.54
-0.47
2.57
10.9
4.97
5.42
15.2
Long-term debt
0.01
0.01
0.06
0.04
Lease liabilities
2.08
Total liabilities
0.01
0.09
0.97
3.55
-0.47
2.7
11.1
5.34
5.49
17.3
Total debt
2.51
0.12
0.04
Paid-in capital
1.86
1.96
5.32
10.1
14.4
34.1
36.4
77.5
112
135
Retained earnings
-0.31
-0.69
-5.71
-13.3
-21.8
-36.5
-44.6
-71.9
-110
-146
Treasury stock
-0.02
-0.05
-0.37
-0.06
-0.06
-0.08
Other comprehensive income
-0.01
-0.04
-0.08
-0.14
Shareholders' equity
1.55
-1.45
-0.36
-2.91
-7.37
-2.49
-8.56
5.45
1.81
-11.8
Minority interests
0.22
1.88
-0.75
Total equity
1.55
-1.45
-0.36
-2.91
-7.37
-2.49
-8.56
5.45
3.69
-12.5
Total liabilities and equity
1.56
1.36
0.61
0.38
0.18
0.21
2.57
10.8
9.17
4.82
Shares outstanding
0.99
0.94
9.53
11.3
13.2
2.16
3.01
8.73
16.7
39
Cash flow statement
FY2013
FY2014
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
Net income
-0.08
-0.38
-3.34
-7.39
-8.75
-12
-8.04
-24.2
-37.4
-35.7
Depreciation and amortization
-0
0.01
0.01
0.04
0.04
0.04
0.06
0.16
0.4
0.59
Stock-based compensation
0.82
0.46
1.26
0.35
0.44
6.86
9.66
4.18
Change in receivables
-0
-0
-0
-0.01
-0.05
-0.09
-0.08
-0.76
Change in inventory
0.01
0.02
-0.04
-0.48
Change in payables
-0.02
0.83
0.86
1.04
0.99
2.88
1.71
4.77
Cash from operations
-0.12
-0.27
-2.29
-2.52
-3.85
-4.97
-5.96
-7.34
-20.5
-16.8
Capital expenditures
-0.05
-0.33
-0.07
-0.04
-0.01
-0.03
-0.03
-0.04
-0.1
-0.21
Acquisitions
-0.34
Purchases of investments
-0.25
Sales and maturities of investments
0.04
0.04
Cash from investing
-0.06
-0.37
-0.07
-0.04
-0.01
-0.03
-0.36
-0.55
-1.17
0.37
Debt issued
0.55
1.44
0.79
1.5
0.75
2.22
Debt repaid
-0.05
-0.1
-0.26
-0.03
-0.49
-0.46
Stock issued
1.71
0.01
2.79
6.67
5.67
5.72
Share buybacks
-0.02
-0.03
-0.02
Cash from financing
1.65
0.13
2.67
2.3
3.8
4.89
6.34
15.8
17.6
13.4
Exchange rate effect
-0.01
-0.03
-0.04
-0.06
Net change in cash
-0.06
-0.11
0.01
7.9
-4.11
-3.09
Free cash flow
-0.17
-0.59
-2.36
-2.56
-3.87
-5
-5.98
-7.39
-20.6
-17
Interest paid
0.03
0.01
0
0.06
0.06
0.18
0.06
0.65
Key metrics
Worked out from the statements above. Latest values use fiscal 2022. Valuation uses the share price of $4.25 on September 28, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
-27.4%
Gross profit / revenue.
Operating margin
-605.3%
Operating income / revenue.
EBITDA margin
-593.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-743.8%
Pre-tax income / revenue.
Net margin
-673.3%
Net income / revenue.
FCF margin
-354.8%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-350.4%
Cash from operations / revenue.
Return on assets (ROA)
-461.6%
Net income / average total assets.
R&D / revenue
19.8%
Research and development expense / revenue.
Stock-based pay / revenue
87.2%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
4.4%
Capital expenditures / revenue.
D&A / revenue
12.2%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
11.6%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
119.6%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
118.8%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-750.3%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-47.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
23.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
93.6%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
74.2%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
100.3%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
11.3%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.10x
Current assets / current liabilities.
Quick ratio
0.06x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.05x
(Cash + short-term investments) / current liabilities.
Debt / assets
0.8%
Total debt / total assets.
Liabilities / assets
359.4%
Total liabilities / total assets.
Net debt
-$668.2K
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$1.60
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$1.66
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.22
Revenue / diluted weighted shares.
FCF per share
-$0.77
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.76
Cash from operations / diluted weighted shares.
Book value per share
-$0.30
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
2.93x
Market cap / revenue.
EV/Sales
2.79x
Enterprise value / revenue.
FCF yield
-121.1%
Free cash flow / market cap.
Earnings yield
-229.9%
Net income / market cap (the inverse of P/E).
Shareholder yield
0.1%
(Dividends paid + share buybacks) / market cap.
What was Creatd, Inc.'s revenue in fiscal 2022?
Creatd, Inc. reported revenue of $4.8M for fiscal 2022, 11.6% higher than the year before.
Was Creatd, Inc. profitable in fiscal 2022?
No. It reported a net loss of $32.3M.
How much free cash flow did Creatd, Inc. generate in fiscal 2022?
Cash from operations of $16.8M minus capital expenditures of $212.2K left free cash flow of -$17.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.